IT1184271B - Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci - Google Patents

Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci

Info

Publication number
IT1184271B
IT1184271B IT47927/85A IT4792785A IT1184271B IT 1184271 B IT1184271 B IT 1184271B IT 47927/85 A IT47927/85 A IT 47927/85A IT 4792785 A IT4792785 A IT 4792785A IT 1184271 B IT1184271 B IT 1184271B
Authority
IT
Italy
Prior art keywords
prophylaxis
beta
treatment
pharmaceutical composition
composition containing
Prior art date
Application number
IT47927/85A
Other languages
English (en)
Other versions
IT8547927A0 (it
Inventor
Agustin Escobar
Dietmar M Wagenknecht
Ahmad Waseem Malick
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of IT8547927A0 publication Critical patent/IT8547927A0/it
Application granted granted Critical
Publication of IT1184271B publication Critical patent/IT1184271B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L65/00—Network arrangements, protocols or services for supporting real-time applications in data packet communication
    • H04L65/1066—Session management
    • H04L65/1083—In-session procedures
    • H04L65/1095—Inter-network session transfer or sharing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Multimedia (AREA)
  • Cardiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT47927/85A 1984-04-09 1985-04-05 Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci IT1184271B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59806184A 1984-04-09 1984-04-09

Publications (2)

Publication Number Publication Date
IT8547927A0 IT8547927A0 (it) 1985-04-05
IT1184271B true IT1184271B (it) 1987-10-22

Family

ID=24394068

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47927/85A IT1184271B (it) 1984-04-09 1985-04-05 Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci

Country Status (9)

Country Link
US (1) US5017609A (it)
EP (1) EP0179808B1 (it)
JP (1) JPH0720861B2 (it)
AU (1) AU575153B2 (it)
CA (1) CA1242395A (it)
DE (1) DE3584560D1 (it)
IT (1) IT1184271B (it)
WO (1) WO1985004580A1 (it)
ZA (1) ZA852316B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000509B (el) * 1988-06-08 1992-07-30 Du Pont Μεθοδος παρασκευης σταθερης ενεσιμης υδατικης συνθεσεως υδροχλωρικου 3-[4-(2-υδροξυ-3-ισοπροπυλαμινο) προποξυ]-φαινυλοπροπιονικου μεθυλεστερα.
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
US6310094B1 (en) * 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
IL160570A0 (en) * 2001-09-26 2004-07-25 Baxter Int Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
BRPI0508798A (pt) * 2004-04-07 2007-09-04 Ares Trading Sa formulação lìquida de hormÈnio de crescimento, composição farmacêutica, forma de apresentação da formulação lìquida de hormÈnio de crescimento e uso da formulação lìquida de hormÈnio de crescimento
PL1773307T3 (pl) * 2004-07-30 2015-03-31 Novartis Ag Preparaty 2-amino-1,3-propanodioli i ich analogów
CA2608930A1 (en) * 2005-06-14 2006-12-28 Baxter International Inc. Pharmaceutical formulations for minimizing drug-drug interactions
AU2006315177A1 (en) * 2005-11-15 2007-05-24 Baxter Healthcare S.A. Compositions of lipoxygenase inhibitors
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
AU2014203121B2 (en) * 2007-05-22 2016-04-21 Baxter Healthcare Sa Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
DK2234614T3 (da) * 2007-12-21 2013-02-11 Aop Orphan Pharmaceuticals Ag Farmaceutisk sammensætning til parenteral administration af et ultrakort virkende beta-receptorblokerende middel
JP5558573B2 (ja) 2009-09-22 2014-07-23 ヴイライフ サイエンシズ テクノロジーズ プライベート リミテッド 糖尿病性足潰瘍用の局所用製剤
AU2012211309B2 (en) 2011-01-27 2014-10-09 Baxter Healthcare Sa Use of (S) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder
CN103338763A (zh) 2011-01-27 2013-10-02 巴克斯特国际公司 治疗心动过速和/或控制心率同时最小化和/或控制低血压的方法
CN104473869A (zh) * 2014-11-20 2015-04-01 北京京科泰来科技有限公司 一种艾司洛尔脂肪乳及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
DE1643262C3 (de) * 1967-12-13 1975-06-26 C.H. Boehringer Sohn, 6507 Ingelheim i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3015991A1 (de) * 1980-04-25 1981-11-05 C.H. Boehringer Sohn, 6507 Ingelheim Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zur ihrer herstellung
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents

Also Published As

Publication number Publication date
AU575153B2 (en) 1988-07-21
DE3584560D1 (de) 1991-12-05
AU4150785A (en) 1985-11-01
CA1242395A (en) 1988-09-27
EP0179808A4 (en) 1987-10-27
US5017609A (en) 1991-05-21
ZA852316B (en) 1985-11-27
EP0179808A1 (en) 1986-05-07
WO1985004580A1 (en) 1985-10-24
IT8547927A0 (it) 1985-04-05
EP0179808B1 (en) 1991-10-30
JPS61501775A (ja) 1986-08-21
JPH0720861B2 (ja) 1995-03-08

Similar Documents

Publication Publication Date Title
IT1184271B (it) Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
IT1190466B (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
ZA857081B (en) Composition for the treatment of allergy
IT8519390A0 (it) Procedimento per la monoepossida zione di composti contenenti due doppi legami
IT1179067B (it) Composto e composizione farmaceutica per il trattamento della osteoporosi
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
IL88159A0 (en) Salts of pentamidine and pharmaceutical compositions containing the same
IT8547928A0 (it) Composizioni farmaceutiche stabili di agenti di blocco dei recettori beta-adrenergici per la profilassi ed il trattamento di disordini cardiaci
IT8448983A1 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
IT8567298A0 (it) Procedimento per la preparazione di 14 idrossi n etossicarbonil norco deinone
IT8748403A0 (it) Composizione di fluoruro a lento rilascio per il trattamento e la prevenzione di affezioni ossee
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
IT8567535A0 (it) Procedimento per la preparazione di amminoidrossicefamcarbossilati
GB2165453B (en) Pharmaceutical agent for the local treatment of psoriasis
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
GB8526645D0 (en) Treatment of surfaces & compositions
IT1199114B (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione
ZA86370B (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
IT8467183A1 (it) Composizione farmaceutica per la profilassi ed il trattamento dell'arteriosclerosi.
IT1175989B (it) Procedimento per la preparazione di polifenileteri
IT1175808B (it) Procedimento per la preparazione di composto con attivita' antiulcera

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423